Colorectal Cancer and Small Bowel AdenocarcinomaPhase 1NCT07417488
Lm-GUCY2C vaccine
GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas
Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")
What the film says
This trial is for colorectal cancer that has spread to the peritoneum, the lining of the abdomen.
The idea: deliver immune cells two ways, by vein and directly into the abdomen. Natural killer cells are engineered to recognize TROP2 and to carry the signal IL-15, with the TGF-beta receptor 2 gene switched off. They are given with cetuximab, an antibody medicine, after chemotherapy that lowers existing lymphocytes.
First the study looks for the highest dose that can be given. Then it asks whether that dose can help control the disease. At MD Anderson in Houston, Paula Smith leads it.
Public record; not medical advice.
Sources behind this film
Colorectal cancer spread to the peritoneum; Cells by vein and directly into the abdomen; NK cells engineered for TROP2 and IL-15, TGFBR2 knocked out; With cetuximab, after chemotherapy that lowers existing lymphocytes (+2 more lines)
The drug
Primary Objective and Endpoints Objective: Determine the safety, and Maximum Tolerated Dose (MTD), Recommended Phase 2 Dose (RP2D), schedule of iterative delivery of dual administration of IP/IV TROP2 CAR/IL-15 TGFBR2 KO NK cells Cell Therapy + IV Cetuximab
The study
To find the highest dose of NK cells that can be given by vein and intraperitoneally (given directly into the abdominal cavity) in combination with cetuximab to patients with colorectal cancer that has spread to the peritoneum.
Eligibility
Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.
For you, or someone you love
A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.
Then $9 a month. Cancel anytime.
Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.
Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.
Ask about your own file, and walk in with questions for your oncologist or the trial team.
Share one profile with the family helping you, and with your doctors.
Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.